The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALIMERA SCIENCES INC | COM | 016259103 | 6,365 | 6,180,033 | SH | SOLE | 6,180,033 | 0 | 0 | ||
| MEDICREA INTERNATIONAL | COM | F6112U109 | 2,778 | 714,729 | SH | SOLE | 714,729 | 0 | 0 | ||
| AMARIN CORP PLC -ADR | SPONS ADR NEW | 023111206 | 17,342 | 5,761,581 | SH | SOLE | 5,761,581 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 16,151 | 2,577,996 | SH | SOLE | 2,577,996 | 0 | 0 | ||
| AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 287 | 20,374 | SH | SOLE | 20,374 | 0 | 0 | ||
| BIODELIVERY SCIENCES INTL | COM | 09060J106 | 8,339 | 3,706,084 | SH | SOLE | 3,706,084 | 0 | 0 | ||
| BIOSPECIFICS TECHNOLOGIES | COM | 090931106 | 26,162 | 590,025 | SH | SOLE | 590,025 | 0 | 0 | ||
| CONFORMIS INC | COM | 20717E101 | 4,028 | 2,777,711 | SH | SOLE | 2,777,711 | 0 | 0 | ||
| CANCER GENETICS INC | COM | 13739U104 | 2,925 | 1,772,741 | SH | SOLE | 1,772,741 | 0 | 0 | ||
| CUMBERLAND PHARMACEUTICALS | COM | 230770109 | 8,838 | 1,323,041 | SH | SOLE | 1,323,041 | 0 | 0 | ||
| CARDIOME PHARMA CORP | COM NO PAR | 14159U301 | 7,520 | 3,241,550 | SH | SOLE | 3,241,550 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM NEW | 12648L601 | 20,053 | 5,141,746 | SH | SOLE | 5,141,746 | 0 | 0 | ||
| DOVA PHARMACEUTICALS INC | COM | 25985T102 | 4,990 | 184,000 | SH | SOLE | 184,000 | 0 | 0 | ||
| EVOLUS INC | COM | 30052C107 | 535 | 59,229 | SH | SOLE | 59,229 | 0 | 0 | ||
| EYENOVIA INC | COM | 30234E104 | 365 | 39,902 | SH | SOLE | 39,902 | 0 | 0 | ||
| FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 666 | 129,756 | SH | SOLE | 129,756 | 0 | 0 | ||
| GEMPHIRE THERAPEUTICS INC | COM | 36870A108 | 1,581 | 242,812 | SH | SOLE | 242,812 | 0 | 0 | ||
| IMMUNE DESIGN CORP | COM | 45252L103 | 532 | 161,226 | SH | SOLE | 161,226 | 0 | 0 | ||
| INVUITY INC | COM NEW | 46187J205 | 1,952 | 507,028 | SH | SOLE | 507,028 | 0 | 0 | ||
| NOVELION THERAPEUTICS INC | COM NEW | 67001K202 | 6,510 | 1,860,000 | SH | SOLE | 1,860,000 | 0 | 0 | ||
| INVITAE CORP | COM | 46185L103 | 1,027 | 219,022 | SH | SOLE | 219,022 | 0 | 0 | ||
| OPHTHOTECH CORP | COM | 683745103 | 4,365 | 1,593,119 | SH | SOLE | 1,593,119 | 0 | 0 | ||
| OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 3,286 | 263,974 | SH | SOLE | 263,974 | 0 | 0 | ||
| SCYNEXIS INC | COM | 811292101 | 509 | 380,083 | SH | SOLE | 380,083 | 0 | 0 | ||
| SIERRA ONCOLOGY INC | COM | 82640U107 | 1,182 | 570,987 | SH | SOLE | 570,987 | 0 | 0 | ||
| STEADYMED LTD | SHS | M84920103 | 2,344 | 721,308 | SH | SOLE | 721,308 | 0 | 0 | ||
| VERACYTE INC | COM | 92337F107 | 4,303 | 773,889 | SH | SOLE | 773,889 | 0 | 0 | ||
| VIVEVE MEDICAL INC | COM NEW | 92852W204 | 14,090 | 3,849,711 | SH | SOLE | 3,849,711 | 0 | 0 | ||
| VANDA PHARMACEUTICALS INC | COM | 921659108 | 16,590 | 984,584 | SH | SOLE | 984,584 | 0 | 0 | ||
| ZOSANO PHARMA CORP | COM NEW | 98979H202 | 1,008 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||